Iel Ltd vs Saroja Pharma Industries India Ltd Stock Comparison
Iel Ltd vs Saroja Pharma Industries India Ltd Stock Comparison
Last Updated on: Mar 20, 2026
Key Highlights
The Latest Trading Price of IEL Ltd is ₹ 6.25 as of 20 Mar 16:01
. The P/E Ratio of IEL Ltd changed from 24.5 on March 2021 to 156.7 on March 2025 . This represents a CAGR of 44.94% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of IEL Ltd changed from ₹ 3.35 crore on March 2021 to ₹ 61.28 crore on March 2025 . This represents a CAGR of 78.84% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The revenue of IEL Ltd for the Dec '25 is ₹ 0.58 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of IEL Ltd for the Dec '25 is ₹ 0.48 crore as compare to the Sep '25 ebitda of ₹ -0.13 crore. This represent the decline of -469% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of IEL Ltd changed from ₹ 0.31 crore to ₹ 0.47 crore over 7 quarters. This represents a CAGR of 26.85%
The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The Dividend Payout of IEL Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About IEL Ltd
IEL Limited was formerly known as Indian Extractions Limited, which incorporated as private limited Company on February 6, 1956.
The name of the Company was changed on January 21, 2019 to IEL Limited.
The Company is into the trading business of Chemicals and Marketing Support Services.
The Company set up a solvent extraction plant at Jamnagar with an installed capacity to process 50 MT of de-oiiled cakes per day.
Subsequently the capacity was increased to 200 MT per day, modern refinery was also commissioned and expanded as the capacity of the extraction plant increased.
The Company had diversified into the field of organic chemicals and dye intermediates by setting up a factory at Vapi for the manufacture of nitrochloro anilines with an installed capacity of 100 MT p.a. and subsequently increased to 180 TPA
The company Undertook expansion and modernisation of its capacity in the extraction and chemical plant.
About Saroja Pharma Industries India Ltd
Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023.
Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business.
In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.
FAQs for the comparison of IEL Ltd and Saroja Pharma Industries India Ltd
Which company has a larger market capitalization, IEL Ltd or Saroja Pharma Industries India Ltd?
Market cap of IEL Ltd is 79 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr
What are the key factors driving the stock performance of IEL Ltd and Saroja Pharma Industries India Ltd?
The stock performance of IEL Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for IEL Ltd and Saroja Pharma Industries India Ltd?
As of March 20, 2026, the IEL Ltd stock price is INR ₹6.08. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹29.6.
How do dividend payouts of IEL Ltd and Saroja Pharma Industries India Ltd compare?
To compare the dividend payouts of IEL Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.